{"created":"2023-05-15T11:52:33.056161+00:00","links":{},"metadata":{"_buckets":{"deposit":"4ddbfc68-2381-4ba3-8f52-2207899e7745"},"_deposit":{"id":"1453.1","owners":[2],"pid":{"revision_id":0,"type":"depid","value":"1453.1"},"status":"published"},"_oai":{"id":"oai:miyazaki-u.repo.nii.ac.jp:00001453.1","sets":["72:30"]},"author_link":["8016"],"item_10001_biblio_info_7":{"attribute_name":"書誌情報","attribute_value_mlt":[{"bibliographicIssueDates":{"bibliographicIssueDate":"2002","bibliographicIssueDateType":"Issued"},"bibliographicIssueNumber":"9","bibliographicPageEnd":"241","bibliographicPageStart":"240","bibliographicVolumeNumber":"20","bibliographic_titles":[{"bibliographic_title":"Pharma medica","bibliographic_titleLang":"en"}]}]},"item_10001_description_5":{"attribute_name":"抄録","attribute_value_mlt":[{"subitem_description":"2000年5月に上市された新しいベンゾジアゼピン系の抗てんかん薬クロバザムは,国内ではゾニサミド以来11年ぶりの部分発作および全般発作の両方にわたり広い治療効果スペクトルを有する新薬である｡20年以上にわたり既存の抗てんかん薬で加療されてきたが発作のコントロールが不良であった症例に,クロバザムを追加投与し,著効を示した症例を報告する｡","subitem_description_language":"ja","subitem_description_type":"Abstract"}]},"item_10001_publisher_8":{"attribute_name":"出版者","attribute_value_mlt":[{"subitem_publisher":"メディカルレビュー社","subitem_publisher_language":"ja"}]},"item_10001_source_id_11":{"attribute_name":"書誌レコードID","attribute_value_mlt":[{"subitem_source_identifier":"AN10042412","subitem_source_identifier_type":"NCID"}]},"item_10001_source_id_9":{"attribute_name":"ISSN","attribute_value_mlt":[{"subitem_source_identifier":"02895803","subitem_source_identifier_type":"ISSN"}]},"item_10001_version_type_20":{"attribute_name":"著者版フラグ","attribute_value_mlt":[{"subitem_version_resource":"http://purl.org/coar/version/c_970fb48d4fbd8a85","subitem_version_type":"VoR"}]},"item_creator":{"attribute_name":"著者","attribute_type":"creator","attribute_value_mlt":[{"creatorNames":[{"creatorName":"植田, 勇人","creatorNameLang":"ja"},{"creatorName":"ウエダ, ユウト","creatorNameLang":"ja-Kana"}],"nameIdentifiers":[{"nameIdentifier":"8016","nameIdentifierScheme":"WEKO"}]}]},"item_files":{"attribute_name":"ファイル情報","attribute_type":"file","attribute_value_mlt":[{"accessrole":"open_date","date":[{"dateType":"Available","dateValue":"2020-06-21"}],"displaytype":"detail","filename":"4-1a.pdf","filesize":[{"value":"414.4 kB"}],"format":"application/pdf","licensetype":"license_note","mimetype":"application/pdf","url":{"label":"4-1a.pdf","url":"https://miyazaki-u.repo.nii.ac.jp/record/1453.1/files/4-1a.pdf"},"version_id":"70c5594f-9113-4d90-89ed-05513a490c9b"}]},"item_language":{"attribute_name":"言語","attribute_value_mlt":[{"subitem_language":"jpn"}]},"item_resource_type":{"attribute_name":"資源タイプ","attribute_value_mlt":[{"resourcetype":"journal article","resourceuri":"http://purl.org/coar/resource_type/c_6501"}]},"item_title":"クロバザム(マイスタン®)の追加投与が奏効した症候性局在関連性てんかんの2症例","item_titles":{"attribute_name":"タイトル","attribute_value_mlt":[{"subitem_title":"クロバザム(マイスタン®)の追加投与が奏効した症候性局在関連性てんかんの2症例","subitem_title_language":"ja"}]},"item_type_id":"10001","owner":"2","path":["30"],"pubdate":{"attribute_name":"公開日","attribute_value":"2009-08-26"},"publish_date":"2009-08-26","publish_status":"0","recid":"1453.1","relation_version_is_last":true,"title":["クロバザム(マイスタン®)の追加投与が奏効した症候性局在関連性てんかんの2症例"],"weko_creator_id":"2","weko_shared_id":2},"updated":"2025-06-01T23:48:36.953030+00:00"}